LAM
EW icon

LECAP Asset Management’s Edwards Lifesciences EW Stock Holding History

LECAP Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,176
Closed -$575K – 303
2026
Q1 		$575K Sell
7,176
-5,388
-43% -$444K 0.22% 178
2025
Q4 		$1.07M Buy
+12,564
New +$1.03M 0.43% 87
2025
Q3 		– Sell
-12,842
Closed -$1M – 317
2025
Q2 		$1M Sell
12,842
-27,295
-68% -$2.04M 0.36% 110
2025
Q1 		$2.91M Buy
+40,137
New +$2.87M 0.68% 29
2024
Q4 		– Sell
-61,831
Closed -$4.08M – 327
2024
Q3 		$4.08M Buy
+61,831
New +$4.49M 0.88% 12

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

LECAP Asset Management's EW Position: Q2 2026 in Review

LECAP Asset Management sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 7,176 shares — an estimated $575K sold.

LECAP Asset Management first reported a position in EW in Q3 2024 and held it in 5 quarters. The position peaked at $4.08M in Q3 2024. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • LECAP Asset Management reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • LECAP Asset Management sold 7,176 Edwards Lifesciences shares in Q2 2026, an estimated $575K.
  • LECAP Asset Management first reported a position in Edwards Lifesciences in Q3 2024 and held it in 5 quarters.
  • LECAP Asset Management's Edwards Lifesciences position peaked at $4.08M in Q3 2024.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.